Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
liver cancer
Biotech
Tempest lays off 80% of workforce to ride out cash crunch
Days after starting to look for partners, the company has moved to lay off 21 of its 26 full-time employees to stretch its limited cash reserves.
Nick Paul Taylor
Apr 21, 2025 8:20am
Boston Scientific to buy chemo pump implant for liver tumors
Nov 25, 2024 12:00pm
HistoSonics nets $102M for sound-powered liver cancer therapy
Aug 15, 2024 12:45pm
FDA clears its first fingerstick hepatitis C diagnostic test
Jul 2, 2024 11:04am
Tempest's triplet shows boost over Roche combo in liver cancer
Oct 11, 2023 11:00am
HistoSonics nets de novo nod for liver tumor-blasting ultrasound
Oct 9, 2023 3:00pm
